← Leaderboards
Mallory L. Hacker
Vanderbilt University Medical Center
$1,020,583
Attributed
$1,020,583
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $251.2K · FY2018–25$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,020,583 · 2
By mechanism
K01$595,536 · 1
R21$425,047 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Aaron B Bowman$18,939,866
- Myrick C Shinall$950,846
- Anna R Hemnes$10,524,693
- Lorraine B Ware$25,185,641
- Lang Wu$6,302,769
Others in their field
Other Emerging Leaders on “Motor”
- James Dale Berry · Brigham And Women'S Hospital$16,144,018
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
- Shadi Dayeh · University Of California, San Diego$13,862,272
- Carla M Bann · Research Triangle Institute$12,326,135
- Bjorn E Oskarsson · Mayo Clinic Jacksonville$11,846,278
- Afonso C Silva · University Of Pittsburgh At Pittsburgh$11,554,502
Research focus
MotorPharmaceutical PreparationsEnrollmentMetabolicNeurodegenerative DisordersParkinson DiseaseDyskinetic SyndromeElectron TomographyFluorodeoxyglucose Positron Emission TomographyInvestigationAffectMotor SymptomDeep Brain StimulationBiochemical PathwayBradykinesiaActivities Of Daily LivingAmericanEarly TreatmentCommunitiesFda ApprovedFutureInpatientsClinical TrialsPilot Trial
Grant awards (7)
Feasibility of Objective Measures and Outpatient Washout in Disease-Modifying Trials for Parkinson's Disease$114,828
K01 · FY2025 · AG · contact PI
Feasibility of Objective Measures and Outpatient Washout in Disease-Modifying Trials for Parkinson's Disease$120,177
K01 · FY2024 · AG · contact PI
Feasibility of Objective Measures and Outpatient Washout in Disease-Modifying Trials for Parkinson's Disease$120,177
K01 · FY2023 · AG · contact PI
Feasibility of Objective Measures and Outpatient Washout in Disease-Modifying Trials for Parkinson's Disease$120,177
K01 · FY2022 · AG · contact PI
Feasibility of Objective Measures and Outpatient Washout in Disease-Modifying Trials for Parkinson's Disease$120,177
K01 · FY2021 · AG · contact PI
Investigating Long-Term Clinical Outcomes and Metabolic Network Activity Following Subthalamic Nucleus Deep Brain Stimulation in Early Stage Parkinson's Disease$173,892
R21 · FY2019 · NS · contact PI
Investigating Long-Term Clinical Outcomes and Metabolic Network Activity Following Subthalamic Nucleus Deep Brain Stimulation in Early Stage Parkinson's Disease$251,155
R21 · FY2018 · NS · contact PI